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Group A streptococcal severe soft tissue infections, such as necrotizing fasciitis, are rapidly
progressive infections associated with high mortality. Group A streptococcus is typically
considered an extracellular pathogen, but has been shown to reside intracellularly in host cells.
Methods and Findings
We characterized in vivo interactions between group A streptococci (GAS) and cells involved
in innate immune responses, using human biopsies (n¼70) collected from 17 patients with soft
tissue infections. Immunostaining and in situ image analysis revealed high amounts of bacteria
in the biopsies, even in those collected after prolonged antibiotic therapy. Viability of the
streptococci was assessed by use of a bacterial viability stain, which demonstrated viable
bacteria in 74% of the biopsies. GAS were present both extracellularly and intracellularly within
phagocytic cells, primarily within macrophages. Intracellular GAS were predominantly noted in
biopsies from newly involved tissue characterized by lower inflammation and bacterial load,
whereas purely extracellular GAS or a combination of intra- and extracellular GAS dominated in
severely inflamed tissue. The latter tissue was also associated with a significantly increased
amount of the cysteine protease streptococcal pyrogenic exotoxin SpeB. In vitro studies
confirmed that macrophages serve as reservoirs for viable GAS, and infection with a speB-
deletion mutant produced significantly lower frequencies of cells with viable GAS following
infection as compared to the wild-type bacteria.
Conclusions
This is the first study to demonstrate that GAS survive intracellularly in macrophages during
acute invasive infections. This intracellular presence may have evolved as a mechanism to avoid
antibiotic eradication, which may explain our finding that high bacterial load is present even in
tissue collected after prolonged intravenous antibiotic therapy. This new insight into the
pathogenesis of streptococcal soft tissue infections highlights a need for alternative
therapeutic strategies.
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Severe invasive group A streptococcal diseases, including
streptococcal toxic shock syndrome (STSS) and necrotizing
fasciitis (NF), are rapidly progressive invasive diseases
associated with signiﬁcant morbidity and mortality [1,2].
There is evidence that streptococcal superantigens are
important inducers of potent inﬂammatory responses that
contribute to these severe invasive manifestations [3–5]. To
date at least 11 distinct superantigens expressed by GAS have
been identiﬁed, all of which are potent inducers of proin-
ﬂammatory responses [5,6]. The ﬁnding that the human
leukocyte antigen class II haplotype of the individual
determines the magnitude of the superantigen-induced
cytokine response and subsequently the severity of invasive
group A streptococcal infection was a major breakthrough in
the understanding of the pathogenesis of these infections [7].
More important, the study revealed distinct risk and
protective human leukocyte antigen class II associations,
depending on whether the patient had STSS or NF. This
strongly supports the notion that STSS and NF are distinct
clinical entities and that the pathogenic mechanisms leading
to each disease may be, at least partly, different.
Although typically considered an extracellular organism,
viable GAS have been found intracellularly in epithelial and
endothelial cells [8–11] and in neutrophils [12]. Several
factors have been suggested to play a role in the internal-
ization process. Among the most well-characterized ones are
the ﬁbronectin-binding proteins [13]. Also secreted factors,
such as streptolysin O [14,15] and the cysteine protease (i.e.,
SpeB) [16,17], have been suggested to be involved, but the
deﬁnite mechanisms and factors involved in the internal-
ization event remain to be elucidated as is evident by the
many contradicting reports on this topic (reviewed in [18]).
SpeB is a potent protease that can cleave numerous
important human proteins, including extracellular matrix
proteins, immunoglobulin, IL1b precursor, and LL37 [19–22].
However, it may also degrade several important streptococcal
virulence factors, which results in attenuation of certain
virulence properties [23,24]. Rasmussen and Bjo ¨rck [25]
suggested that these proteolytic events are tightly regulated
bothtemporallyandspatiallyanddiffer,dependingonthestage
of infection. This could explain the varying results from in vivo
studies in experimental models and patients’ cohorts, some of
whichimplicateSpeBinthediseaseprocess[17,26–29],whereas
others show an attenuation of virulence if SpeB is expressed
[30–32]. Another plausible explanation is that the deﬁned role
of SpeB may vary depending on the site of infection, for
example, systemic bacteremia versus tissue infection.
We aimed to investigate the pathogenic mechanisms
involved in acute group A streptococcal soft tissue infections.
The study is based largely on clinically well-deﬁned human
tissue biopsy material, consisting of biopsies from areas more
or less inﬂamed and obtained from the same patient, thereby
allowing for conclusions regarding the relationship between
local disease severity and in vivo expression of host and
bacterial factors without bias from infecting strain or speciﬁc
host properties. We have previously utilized this material to
visualize and quantify in vivo host–pathogen interplay with
special focus on superantigens and cytokine expression
proﬁles [4]. We extended these analyses to characterize the
interaction of GAS with cells of the innate immune system.
Methods
Patient Material
The study is based on tissue biopsies (n¼70) collected from
17 patients with various soft tissue infections, including NF (n
¼14), myositis (n ¼1), and cellulitis (n ¼ 2), caused by GAS of
varying serotypes, including M1T1, M3T3, M6T6, M28T28,
and M4. The patients were identiﬁed through active surveil-
lance in Ontario, Canada, during 1995–1997. All patients
received intravenous clindamycin in combination with a b-
lactam antibiotic at admission. The biopsy material was
collected and stored as described in our previous report [4].
Biopsies, including skin, subcutaneous tissue, muscle, or
fascia, were collected at surgical procedures performed on
different days, ranging from 1–20 d after diagnosis. In several
patients (n ¼ 11) biopsies of different clinical grades were
collected at the same time point. The tissue from which
biopsies were taken was graded, based on a clinical assessment
made by one of the investigators (DEL) at the time of
sampling, according to the following deﬁnition. Clinical grade
1¼normal tissue, no evidence of inﬂammation (n¼11). Grade
2 ¼ inﬂamed tissue (erythema and edema), including 2a ¼
cellulitis (inﬂammation of skin or soft tissue, but excluding
fascia and muscle [n¼28]); 2b¼fasciitis (inﬂammation of skin
or soft tissue and fascia [n¼12]); and 2c¼NF (necrotic fascia
[n ¼ 19]). This study was approved by the Human Subjects
Review Committee of the University of Toronto, and
informed consent was obtained from all patients. Clinical
evaluation, classiﬁcation of patients, and cell marker/bacterial
antigen analyses were performed independently and blinded
by different investigators and at different hospitals.
Immunostaining
The following antibodies speciﬁc for human cell markers
were used at predetermined optimal dilutions ranging from
1:10–1:400: anti-CD68 (EBM11, murine IgG1; Dako, Carpin-
teria, California, United States), anti-CD3 (murine IgG1;
Becton-Dickinson, Palo Alto, California, United States), anti-
CD1a (mouse IgG2a; Dako), antineutrophil elastase (NP57,
murine IgG1; Dako). GAS were identiﬁed by use of a
polyclonal rabbit antiserum speciﬁc for the Lanceﬁeld group
A carbohydrate (diluted 1:10,000; Difco, Detroit, Michigan,
United States). In agreement with our previous report [4], the
stainings could be divided into high and low amounts of GAS
by use of a cutoff image analysis value of ﬁve. In vivo
expression of SpeB and SpeF was determined by use of
polyclonal rabbit antisera raised against native SpeB (Toxin
Technology, Sarasota, Florida, United States) or against
recombinant SpeF (produced in the laboratory of MK). Anti-
SpeB and anti-SpeF sera were used at a dilution of 1:2,000 and
1:10,000, respectively. The speciﬁcity of the polyclonal anti-
SpeB antiserum was tested by preincubation of the antiserum
with puriﬁed SpeB. Preincubation with a 10-fold excess of
puriﬁed SpeB effectively blocked staining for the antigen in
the tissue sections. Irrelevant isotype-speciﬁc murine anti-
bodies (Vector Laboratories, Burlingame, California, United
States) and preimmune rabbit sera at appropriate dilutions
were used to control for nonspeciﬁc staining reactions.
Biotinylated secondary antibodies included goat-anti-mouse
IgG1, goat-anti-mouse IgG2a (diluted 1:300; CalTag Labora-
tories, Burlingame, California, United States), and goat-anti-
rabbit IgG (diluted 1:500; Vector Laboratories).
PLoS Medicine | www.plosmedicine.org March 2006 | Volume 3 | Issue 3 | e53 0372
Intracellular Streptococcal ReservoirImmunohistochemical Staining of Tissue Biopsies
The biopsies were cryosectioned, ﬁxed, stained, and
analyzed by image analysis as previously described [4]. The
staining method was modiﬁed to include an initial blocking
step with 20% FCS in BSS-saponin for 30 min at room
temperature followed by 1% normal goat serum for 30 min.
GAS and SpeF antibodies were diluted in Earl’s balanced salt
solution containing saponin and 0.02% NaN3. Addition of
10% FCS was required together with the SpeB antisera to
minimize unspeciﬁc staining. Regardless of the size of the
biopsies, which varied substantially, the whole section was
analyzed by acquired computerized image analysis (ACIA),
yielding an analyzed cell area (deﬁned by the blue hematox-




The results are presented as ACIA values, which equal
percentage positively stained area 3 mean intensity of
positive staining. The majority of negative controls, i.e.,
biopsies stained with isotypic control antibodies, were
completely negative; however, in case of any background
staining, the sections were subjected to ACIA analyses and the
value subtracted from the sample value.
Fluorescent Staining and Confocal Microscopy
Single and double immunostainings were conducted for
GAS and SpeB, GAS and CD68, and GAS and neutrophil
elastase, respectively. The tissue biopsies were sectioned,
ﬁxed, and permeabilized as described above. Tissue sections
were initially blocked with 2% FCS in PBS-saponin for 30 min
followed by avidin and biotin blocking (Vector Laboratories)
for 15 min each. This was followed by blocking with PBS-
saponin containing 0.1% BSA-c (Aurion, Wageningen, The
Netherlands). GAS-, SpeB-, CD68-, secondary antibodies, and
also ﬂuorophores were all diluted in PBS-saponin-BSA-c.
Primary antibodies were incubated overnight. Antibodies
against SpeB were conjugated with EZ-Link NHS-LC-biotin
(Pierce Biotechnology, Rockford, Illinois, United States)
according to the manufacturer’s manual. GAS and CD68
stainings required a 30-min step with biotinylated secondary
antibodies. After incubation with the biotinylated secondary
antibody, streptavidin-conjugated ﬂuorophores (Alexa Fluor
488 diluted 1:600, and Alexa Fluor 546 diluted 1:500;
Molecular Probes, Eugene, Oregon, United States) were added
and incubated for 30 min in the dark. Both the antisera and
the secondary biotinylated antibodies were used at optimized
concentrations. Determination of bacterial viability was
achieved through staining of 16-lm thick biopsy sections
with a live/dead Baclight bacterial viability kit (Molecular
Probes). For evaluation, a Leica confocal scanner TCS SP II
was used, coupled to a Leica DMR microscope (Leica, Wetzlar,
Germany). We used a conservative evaluation of the biopsies,
including the criterion of the presence of a signiﬁcant
number of bacteria (with a bright green ﬂuorescence, intact
morphology, and correct size) in the biopsy in order to be
classiﬁed as positive for viable bacteria. The speciﬁcity of the
viability kit was validated by using antibiotic- and heat-killed
streptococci, as well as a dose-response experiment. In the
latter experiment three different doses (corresponding to a
multiplicity of infection 10, 5, and 1) of live Streptococcus
pyogenes was used for infection of macrophages, and intra-
cellular survival assessed by the viability stain was compared
to bacterial growth on blood agar plates following cell lysis.
The two methods showed a good concordance.
In Vitro Infection of Monocytes and Macrophages
GAS isolates 8157, 5448, and the 5448-derived SpeB in
frame allelic-exchange knockout 5448DSpeB (generated by
Dr.V. Nizet, La Jolla [33]), were used for in vitro infection.
The strains were of M1T1 serotype and isolated from patients
with STSS, including one patient from whom biopsies were
obtained and included in the present biopsy material. The
isolates were grown at 37 8C to stationary phase in Todd-
Hewitt broth (Difco) supplemented with 1.5% yeast extract
(Difco), washed with PBS, and diluted to the required
inoculum (1–2.5:1, bacteria to cell ratio) as determined by
viable counts on sheep blood agar plates. Peripheral blood
mononuclear cells were isolated from buffy coats or from
heparinized venous blood by Ficoll-Hypaque gradient cen-
trifugation. Monocytes were enriched through plastic adher-
ence for 90 min and either used directly after washing, or
allowed to differentiate into macrophages through cell
culture for 7–10 d in RPMI 1640 medium (Gibco, Grand
Island, New York, United States) supplemented with 10%
FCS. GAS isolates were added to washed cells and infection
allowed to proceed for 120 min at 37 8C, 5% CO2, after which
125 lg/ml gentamicin (Gibco) and 2.5 lg/ml Pc-G were added
for 45 min, followed by extensive washing and incubation in
RPMI supplemented with 10% FCS and Pc-G at 1 lg/ml.
Intracellular bacteria were assessed after various time points
by use of the live/dead Baclight bacterial viability kit
(Molecular Probes) in 0.05% saponin to permeabilize cell
membranes. Confocal microscopy was used to determine the
frequency of monocytes/macrophages harboring dead and/or
viable bacteria. More than three viable GAS per cell were
required in order for a cell to be assessed as harboring viable
GAS. Bacterial viability was conﬁrmed at the early time
points by cell lysis in Milli-Q containing 0.025% Triton-X and
subsequent determination of viable counts on blood agar
plates. At the later time points, bacterial growth was assessed
in antibiotic-free medium, as described below. Growth curves
of 5448 wild type and DSpeB were similar.
Bacterial Resurgence into Medium after Antibiotic
Removal
Macrophages were infected with strains 8157 or 5448. At 2
h postinfection, gentamicin (125 lg/ml) and penicillin-G (2.5
lg/ml) were added for 45 min to kill extracellular bacteria.
The cells were then washed three times with PBS and
incubated in RPMI containing 10% FCS and 1 lg/ml of
penicillin-G. At 12 h postinfection, cells were washed three
times with PBS, and fresh antibiotic-free RPMI containing
10% FCS was added. At different time points, samples were
taken from the medium and plated on blood agar plates.
Plates were incubated overnight at 37 8C, and then colonies
were counted.
Statistical Evaluation
Comparisons between groups were performed using a
Mann-Whitney test, Kruskal-Wallis median test, or—in the
case of categorical values—Fisher’s exact test. Deming
regression (i.e., model II linear regression) was used to
examine the relationship between variables. SpeB, SpeF,
and GAS levels were transformed with the square root in
order to normalize the distribution of these variables. p-
Values of less than .05 were considered signiﬁcant.
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High Bacterial Load and Infiltration of Phagocytic Cells at
the Local Site of Infection
In agreement with our previous study [4], all biopsies (n ¼
70) in our expanded clinical material contained varying
amounts of bacteria, with the highest levels noted in biopsies
of higher clinical grade, i.e., severely involved tissue with high
inﬂammation (p , 0.01; Figure 1A). Strikingly, biopsies
obtained more than 3 d after diagnosis of infection and
initiation of intravenous antibiotic (n ¼ 24 biopsies) still
contained GAS, and 50% of those had high amounts of the
bacteria (Figure 1A).
The fact that intact streptococci of normal size (0.8 lm) and,
as presented below, local expression of exotoxins are present
at the site of infection strongly implied that the bacteria
within the tissue were viable. However, bacterial culture
before snap freezing had only been performed on one biopsy.
This biopsy, which had been collected 7 d after diagnosis, was
found positive for GAS growth. To conﬁrm the viability of the
bacteria within the frozen tissue, 19 biopsies were analyzed
using a bacterial viability stain that allows for distinction of
viable and dead bacteria within the tissue. Conservative
evaluation of these stainings, with respect to morphology
and staining intensity, demonstrated viable bacteria in the
majority of biopsies (74%), and most viable bacteria were
found to be associated with host cells (Figure 1B).
To examine whether the high bacterial load could be due to
lack of inﬁltrating phagocytic cells, as was recently suggested
[34], the degree of phagocytic cell inﬁltration in these
biopsies was determined. The majority of biopsies (89%)
contained both neutrophils (i.e., neutrophil elastase-positive)
and macrophages (i.e., CD68-positive, CD1a-negative cells),
with somewhat higher levels of macrophages (Figure 1C). The
phagocytic cellular inﬁltration was generally higher in
biopsies of clinical grade 2—i.e., severely involved tissue
(Figure 1C)—and correlated signiﬁcantly with bacterial load
(p , 0.02; Figure 1D). Essentially no dendritic cells could be
detected in the biopsies, as evident by the lack of CD1a
positive cells.
Intra- and Extracellular Localization of GAS in the Tissue
Immunohistochemical staining for GAS revealed three
distinct staining patterns that were highly reproducible in
each biopsy: intracellular GAS deﬁned by a cytoplasmic
staining pattern (Figure 2A), a combination of intra- and
extracellular bacteria (Figure 2B), and extracellular cocci in
the tissue (Figure 2C). Surprisingly, 43% of the biopsies
showed a pattern of purely intracellular bacteria. The cellular
localizations were conﬁrmed by immunostaining and con-
focal microscopic analyses (Figure 2D). In order to identify
Figure 1. High Bacterial Load and Infiltration of Phagocytic Cells in Tissue Biopsies
Tissue biopsies of clinical grades 1 or 2 (for definitions, see Methods) were stained for the presence of bacteria, macrophages (CD68-positive cells), and
neutrophils (neutrophil elastase-positive cells). The stained biopsies were evaluated by ACIAs, and the ACIA value is shown in the figure; for details, see
Methods.
(A) Percentage of biopsies with low or high bacterial load (indicated by white and black bars, respectively) in biopsies divided according to their clinical
grade (1 or 2) or by time of collection after diagnosis. Numerals within the bars denote number of biopsies. Low or high bacterial is defined by the
threshold ACIA value of  5, as previously described [4]. The viability of GAS in the tissue was assessed by use of a bacterial viability stain that stains
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and various cell markers, including CD1a, CD3, CD68, and
neutrophil elastase, revealed that intact GAS were found
predominantly in macrophages, i.e., CD68-positive, CD1a-
negative cells, although GAS could also be detected within
neutrophils occasionally.
Intracellular bacterial localization was found to be signiﬁ-
cantly more common in biopsies of clinical grade 1, i.e. newly
involved tissue with low inﬂammation and low bacterial load,
than in biopsies of higher clinical grade and excessive
inﬂammation (p , 0.05; Figure 2E). The amount of inﬁltrating
phagocytic cells, bacterial load, or their cellular localization
did not correlate signiﬁcantly to time of tissue collection in
relation to disease onset or to the type of tissue collected
(unpublished data).
In Vivo Expression of SpeB Varies Depending on Bacterial
Localization
Conﬂicting data on the role of the streptococcal cysteine
protease SpeB in the internalization event have been
published [16–18,35–37]. Our tissue material allowed for a
direct assessment of the in vivo expression of SpeB during the
acute infection. SpeB was detected in most biopsies (82%),
and the amount of SpeB showed a positive correlation to the
bacterial load (p ¼ 0.0006; Deming regression; unpublished
data). More important, signiﬁcantly higher amounts of SpeB
was seen in biopsies where GAS were localized both intra-
and extracellularly, as compared to biopsies where the
bacteria were found either intra- or extracellularly (p ¼
0.03; Figure 3A). This expression pattern seems to be unique
to SpeB, since SpeF was found in equal amounts in biopsies
with purely intracellular GAS or those with a combination of
intra- and extracellular GAS. A potential bias due to
treatment could be excluded since a subanalysis, which
involved only biopsies obtained at day 1, showed a similar
correlation between GAS localization and the differential
expression of SpeB and SpeF (unpublished data).
Figure 2. GAS Were Localized Extracellularly or Intracellularly in Phagocytic Cells in the Tissue
Biopsies from patients with tissue infections (n ¼ 70) caused by GAS were cryosectioned and immunostained for GAS. Immunohistochemical staining
revealed three main staining patterns: (A) cytoplasmic, intracellular staining; (B) a combination of intra- and extracellular staining; and (C) extracellular
staining. (D) Confocal microscopy of GAS (Alexa 546, red) and CD68-positive cells (Alexa 488, green) in the tissue. The figure shows a simulated
fluorescence process projection of a sequential scan. The Y–Z area equals the vertical plane. Intracellular streptococci are shown in yellow. (E) Bacterial
localization in relation to clinical grade. Tissue biopsies from patients with tissue infections caused by GAS were classified according to clinical grade
(for definitions, see Methods). Numerals within bars denote number of biopsies. Statistical difference between groups was analyzed using Fisher’s
exact test.
DOI: 10.1371/journal.pmed.0030053.g002
Figure 3. Amount of Spe in Tissue Biopsies with Different Bacterial
Localization
Tissue biopsies were immunohistochemically stained for GAS, SpeB, and
SpeF, and the stainings were quantified by ACIA.
(A) Amount of SpeB and SpeF in biopsies with different bacterial
localization (n ¼ 65 and 67, respectively); Intra, intracellular; Intra/Extra,
intra and extracellular; and Extra, extracellular. Bars show mean 6 SEM.
Statistically significant differences were estimated by a Kruskal-Wallis
median test.
(B) SpeB attached to the bacterial cell surface in a representative tissue
biopsy. Confocal microscopy of immunostainings of GAS (Alexa 546, red)
and SpeB (Alexa 488, green). Colocalized staining is shown in yellow.
DOI: 10.1371/journal.pmed.0030053.g003
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Forms of SpeB In Vivo
Immunostaining for both GAS cell-wall carbohydrates and
SpeB in the tissue biopsies revealed that SpeB could be found
secreted inlarge areasof thetissue,orcolocalized to thegroup
A carbohydrates, i.e., attached to the bacterial surface (Figure
3B). In all SpeB-positive biopsies, the secreted form of SpeB
could be detected, whereas the surface attached form was only
found in ten biopsies obtained from six patients infected with
GAS isolates of varying serotypes. Nine of these ten biopsies
were of severely involved tissue, and seven had a high bacterial
load with GAS located both intra- and extracellularly. The
secreted and surface-attached forms were found in distinct
areas of these biopsies, where the attached form was
predominantly localized to areas with higher cellular density
(i.e., areas with strong hematoxylin nuclear counterstaining).
In Vitro Studies Confirm the Presence of Intracellular
Viable GAS in Macrophages
To conﬁrm our in vivo ﬁndings, the internalization
frequency and intracellular survival of clinical GAS isolates
was analyzed in an in vitro cell culture system, using freshly
isolated human monocytes or monocyte-derived macro-
phages. First we tested whether the internalization frequency
of GAS was affected by the presence of human serum, but no
such effect was found as equal frequencies of cells with viable
GAS were found in cultures with either human serum or fetal
calf serum (unpublished data). The experiments were there-
fore conducted in the absence of human serum to prevent an
inﬂuence of opsonizing antibodies, which is clinically relevant
since studies have shown that patients developing severe
invasive infection lack, or have very low levels of, such
antibodies [38,39]. After an initial infection time of 2 h
followed by killing of extracellular bacteria by antibiotics,
both monocytes and macrophages were found to contain large
numbers of viable bacteria (Figure 4A and 4B). The two
clinical invasive GAS strains used resulted in similar frequen-
cies of infected cells. Approximately 30%–60% of the cells
were found to harbor viable intracellular bacteria at both 4
and 12 h postinfection (Figure 4A), and intracellular viable
bacteria could be detected for up to at least 20 h (unpublished
data). Removal of extracellular antibiotics 12 h postinfection
led to a rapid resurgence of bacteria in the culture medium
after a lag time of about 2 h. An initial 10-fold increase per
hour could be observed for both strains (Figure 4C), which far
exceeded the growth rate of the strains in control experiments
without cells. Although the majority of the intracellular
bacteria were viable, a signiﬁcant number of dead bacteria
were also noted intracellularly (Figure 4B). This is likely the
result of an efﬁcient phagocytic killing; however, some of the
dead bacteria may also represent phagocytosed adherent
bacteria that were killed by the extracellular antibiotic.
Figure 4. GAS Survive Intracellularly in Monocytes and Macrophages
A) Frequency of cells containing viable intracellular bacteria 4 and 12 h postinfection with strains 8157 and 5448, respectively. Bars denote mean 6 SEM
of four or five experiments performed using monocytes or macrophages, respectively.
(B) A confocal image of a representative macrophage harboring intracellular GAS (viable in green and dead in red) as assessed by staining with a
bacterial viability kit. (C) Resurgence of intracellular bacteria (8157 and 5448) in the medium. At 12 h postinfection, antibiotic-free medium was added,
and extracellular growth was monitored in the medium over time. The figure shows one representative out of four experiments performed. Control
experiments lacking live human cells failed to support growth after antibiotic removal (unpublished data).
(D) Comparison of frequencies of cells harboring viable GAS after infection with either 5448 wild-type (WT) strain or its isogenic DSpeB knockout (SpeB
ko). Infected cells were stained with a live/dead BacLight bacterial viability kit, at 4 and 12 h postinfection, and the frequencies of cells containing viable
bacteria in relation to the total number of cells were determined. Mean 6 SEM of five experiments performed is shown. Significant difference in survival
over time was determined by a Mann-Whitney test, and the p-value is indicated.
DOI: 10.1371/journal.pmed.0030053.g004
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process, we compared the wild-type clinical isolate 5448 to its
isogenic speB gene-deletion mutant. The frequencies of cells
with viable GAS were similar at 4 h postinfection; however, at
12 h postinfection, signiﬁcantly lower frequencies of cells
with viable GAS were seen following infection with the speB
mutant as compared to the wild type (p ¼ 0.008; Figure 4D).
Discussion
This study demonstrated that GAS can reside intracellularly
in host phagocytic cells at the local site of tissue infection
during the acute phase. More important, the localization of
GAS varied depending on severity of tissue infection, and the
intracellular localization was most prevalent in noninﬂamed
tissue, which also demonstrated low bacterial load. Both
neutrophils and macrophages were found to harbor intra-
cellular GAS, but intact streptococci were more commonly
observed in macrophages. An intracellular reservoir of GAS in
neutrophils and epithelial cells has previously been shown
through in vitro studies and experimental murine models
[8,9,40]. Furthermore, the study by Osterlund et al. [10]
revealed intracellular GAS present in pharyngeal epithelial
and macrophage-like cells of patients with tonsillitis. Here we
show, for the ﬁrst time, that this occurs in vivo during severe
invasive GAS soft tissue infections in humans, even while
patients are on antibiotic therapy.
The role of macrophages as host cells for intracellular GAS
was further conﬁrmed by in vitro cell culture experiments
demonstrating a high frequency of monocytes and macro-
phages harboring viable GAS. More important, the bacteria
could survive intracellularly for an extended period of time,
and once the antibiotic was removed, a striking extracellular
bacterial growth could be observed. This result implies that
streptococci residing intracellularly in macrophages repre-
sent an important reservoir of bacteria that, once they leave
their host cell, are capable of causing continued infection.
Phagocytic cells are believed to have an essential role in the
host defense against infections, as was recently shown by
Goldmann et al. [41] who reported an important role of
macrophages in the early control of GAS infections. Although
we found that phagocytes manage to kill some of the bacteria,
as evident by the bacterial viability assessment, our data
clearly demonstrate that a high proportion of the internal-
ized bacteria remain viable for an extended period of time
within the phagocytic cells. The underlying explanation for
intracellular killing rather than survival within phagocytes
remains to be elucidated, but it seems likely that the entry
pathway is involved. This theory is supported by our recent
data that addition of polyclonal intravenous immunoglobu-
lins containing opsonizing antibodies signiﬁcantly improved
phagocytic killing of GAS in our cell culture system (LJ, PT,
and ANT, unpublished data). Various mechanisms to pro-
mote intracellular survival in host cells have recently been
suggested, including cytolysin-mediated evasion of lysosomal
killing in nonphagocytic cells [14,15] and utilization of host
cell caveolae as entry port into epithelial and endothelial cells
[11]. The pathway involved in intracellular survival of GAS in
macrophages is as yet unknown.
A clinically important ﬁnding of this study is that super-
antigen-producing GAS could be detected in tissue biopsies
obtained several days (3–24 d) after the onset of infection,
despite ongoing antibiotic therapy (intravenous clindamycin
in combination with a b-lactam antibiotic) during this time
period. One of the biopsies included in this study was assessed
for bacterial growth on a blood agar plate, which revealed
growth of bacteria in areas distant to the biopsy, whereas a
clear inhibitory zone around the biopsy was seen. Hence, the
biopsy contained substances that were toxic to the bacteria.
Whether these are antibiotics and/or other bacteriostatic
substances, such as host antimicrobial peptides, remains an
open issue. However, our data clearly show that despite the
presence of these toxic substances within the biopsy, the
bacteria still resist killing, potentially through the intra-
cellular persistence in host cells. Antibiotic eradication failure
due to an intracellular streptococcal reservoir has previously
been reported for recurrent tonsillitis cases [42,43]. The
results emphasize that alternate approaches to therapy may be
required if we are going to improve the morbidity and
mortality associated with severe GAS soft tissue infections.
The present study also demonstrates, for the ﬁrst time in
patients, that SpeB is secreted at the local site during these
infections. The toxin was found secreted in large areas of the
tissue and, considering the potent proinﬂammatory and
proteolytic activities of SpeB, such high local expression is
likely to contribute to the excessive inﬂammation previously
reported for these tissue infections [4]. In addition, the analyses
showthatthebacterial-attachedformofSpeBoccursinvivo,an
observationthathaspreviouslybeenreportedinvitro[19,44].In
vivo, this phenomenon was observed predominantly in severely
involved tissue with a combination of intra- and extracellular
bacteria and dense cell inﬁltration. Taken together with our
ﬁnding of an intracellular source of streptococci in vivo, these
data could imply that bacterial-attached SpeB may contribute
to this intracellular reservoir through its strepadhesin activity
previously reported by Hyto ¨nen [44]. In vitro infection of
macrophageswith a SpeBmutant conﬁrmeda rolefor SpeBfor
intracellular survival within macrophages. Whether this is
linked to the adherence, internalization pathway, or to some
other mechanism remains to be shown. One intriguing
hypothesis is that the bacterial-attached SpeB could promote
an alternative entry pathway into the macrophages that would
allow the bacteria to avoid phagocytic killing.
Our ﬁnding that intracellular bacteria were most com-
monly found in newly involved tissue with low inﬂammation
and low bacterial load leads us to propose a hypothetical
model that internalization can promote the spread of
bacteria within the tissue. This is in analog to the ﬁsh, and
occasionally also human, pathogen Streptococcus iniae that uses
macrophage-like cells as ‘‘Trojan horses’’ in their natural host
[45]. Studies are currently ongoing to explore whether this
also occurs in GAS soft tissue infections.
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Background. One cause of a very severe soft infection called necrotizing
fasciitis is a bacterium known as group A streptococcus. This infection
can spread very quickly, and it can be fatal. Treatment of this infection
often requires more than antibiotics: for example, removal of the
infected tissue in surgery. Previous work has shown that these bacteria
can live inside cells that would normally kill them.
Why Was This Study Done? The authors wanted to investigate whether
an intracellular streptococci persisting in human cells contributes to the
development and severity of severe soft tissue infections.
What Did the Researchers Do and Find? They looked at 70 tissue
samples taken from 17 people with soft tissue infections. They found
that many live bacteria were present both inside and outside of the cells
that take up bacteria—particularly one type of cell known as a
macrophage—and even when the samples were taken after patients
had had a long course of antibiotics. The bacteria were mostly inside
cells in samples taken from newly infected and less inflamed tissue,
whereas more severely inflamed tissue had bacteria only outside of the
cells or both inside and outside. The authors also showed that the
severely inflamed tissue had increased amounts of an enzyme called
streptococcal pyrogenic exotoxin (SpeB), which destroys some proteins
from infected tissue. Experimental infections with bacteria that had this
enzyme removed led to lower numbers of cells with living bacteria in
them compared with the normal bacteria.
What Do These Findings Mean? It appears that these bacteria can hide
inside cells that should kill them and thus be protected from the effects
of antibiotics. The enzyme SpeB may play an important role in whether
the infection becomes more serious. This study will not affect how
patients with this disease are treated at the moment, but may suggest
further research that needs to be done. Future studies may need to
suggest new ways to get rid of these bacteria.
Where Can I Get More Information Online? MedlinePlus has a Web
page of information and other links on necrotizing fasciitis:
http://www.nlm.nih.gov/medlineplus/ency/article/001443.htm
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